I agree that this site is using cookies. You can find further informations here.
X
Mouret-Reynier, M-A.
144  results:
Search for persons X
?
1

34O ROCSAN: A multicentric randomized phase II/III evaluati..:

Ray-Coquard, I.L. ; Bellesoeur, A. ; Fabbro, M....
ESMO Open.  9 (2024)  - p. 103534 , 2024
Link: https://doi.org/10.1016/..
 
?
2

132P Clinico-pathological characteristics, treatments and s..:

Giugliano, F. ; Bertaut, A. ; Blanc, J....
ESMO Open.  9 (2024)  - p. 103119 , 2024
Link: https://doi.org/10.1016/..
 
?
3

4MO Neoadjuvant letrozole and palbociclib versus chemothera..:

Cottu, P.H. ; Kieffer, Y. ; Lemonnier, J....
ESMO Open.  9 (2024)  - p. 103014 , 2024
Link: https://doi.org/10.1016/..
 
?
4

124P Neoadjuvant durvalumab plus endocrine therapy followin..:

Verret, B. ; Lacroix-Triki, M. ; Ladoire, S....
ESMO Open.  9 (2024)  - p. 103112 , 2024
Link: https://doi.org/10.1016/..
 
?
5

32O 5-year (y) overall survival (OS) with maintenance olapa..:

Lorusso, D. ; Mouret-Reynier, M-A. ; Harter, P....
ESMO Open.  8 (2023)  1 - p. 100812 , 2023
Link: https://doi.org/10.1016/..
 
?
6

180P Immunogenomic profiling of the randomized NeoPembrOv c..:

Le Saux, O. ; Ardin, M. ; Berthet, J....
Immuno-Oncology and Technology.  20 (2023)  - p. 100639 , 2023
Link: https://doi.org/10.1016/..
 
?
7

Predictive and prognostic factors in patients treated by ne..:

Amat, S. ; Chollet, P. ; Belembaogo, E....
The Breast.  12 (2003)  - p. S38-S39 , 2003
Link: https://doi.org/10.1016/..
 
?
8

Event-free Survival with Pembrolizumab in Early Triple-Nega..:

Schmid, P ; Cortes, J ; Dent, R...
New England Journal of Medicine, Vol.386 No.6, pp.556-567.  , 2022
Link: https://hdl.handle.net/1..
 
?
9

Mastectomy With Immediate Breast Reconstruction After Neoad..:

Monrigal, E ; Dauplat, J ; Gimbergues, P...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejso.2011.07.009.  , 2011
Link: https://hal.archives-ouv..
 
?
10

Is Nottingham prognostic index useful after induction chemo..:

Chollet, P ; Amat, S ; Belembaogo, E...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2394297.  , 2003
Link: http://www.ncbi.nlm.nih...
 
?
11

Prognostic significance of a complete pathological response..:

Chollet, P ; Amat, S ; Cure, H...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364175.  , 2002
Link: http://www.ncbi.nlm.nih...
 
?
12

Alpelisib for PIK3CA-mutated, hormone receptor-positive adv..:

Andre F ; Ciruelos E ; Rubovszky G...
info:eu-repo/semantics/altIdentifier/pmid/31091374.  , 2019
Link: http://hdl.handle.net/11..
 
?
13

Prognostic value of EndoPredict test in patients with hormo..:

Penault-Llorca, F. ; Dalenc, F. ; Chabaud, S....
ESMO Open.  9 (2024)  5 - p. 103443 , 2024
Link: https://doi.org/10.1016/..
 
?
14

Neoadjuvant anthracycline-based (5-FEC) or anthracycline-fr..:

Ginzac, Angeline ; Molnar, Ioana ; Durando, Xavier...
Breast Cancer Research and Treatment.  205 (2024)  2 - p. 267-279 , 2024
Link: https://doi.org/10.1007/..
 
?
15

Prognostic stratification ability of the CPS+EG scoring sys..:

Roussot, Nicolas ; Constantin, Guillaume ; Desmoulins, Isabelle...
European Journal of Cancer.  202 (2024)  - p. 114037 , 2024
Link: https://doi.org/10.1016/..
 
1-15